Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Stroke. 2016 Mar;47(3):659–667. doi: 10.1161/STROKEAHA.115.012166

Table 3. Risk of Ischemic Stroke or Central Nervous System Hemorrhage Unadjusted and Adjusted by Potential Confounders.

Model 1* Model 2 Model 3 Model 4
HR (95%) p HR (95%) p HR (95%) p HR (95%)
IL6 continuous (per SD=11.98) 1.1 (1.0, 1.2) 0.010 1.1 (1.0, 1.2) 0.002 1.1 (1.0, 1.2) 0.006 1.1 (1.0, 1.2) 0.014
IL6 0.28 0.28 0.38 0.40
 Quartile 1 (Referent) -- -- -- --
 Quartile 2 0.70 [0.37,1.34] 0.71[0.37,1.36] 0.73[0.38,1.41] 0.74[0.38,1.43]
 Quartile 3 1.29 [0.74,2.26] 1.31[0.74,2.31] 1.27[0.71,2.28] 1.27 [0.71,2.29]
 Quartile 4 1.01[0.56,1.83] 1.07[0.59,1.94] 1.08[0.58,2.01] 1.11[0.60,2.06]
MCP1 continuous (per SD=127.93) 1.1 (0.87, 1.4) 0.47 1.1 (0.89, 1.4) 0.34 1.1 (0.83, 1.4) 0.27 1.1 (0.85, 1.4) 0.52
MCP1 0.37 0.42 0.52 0.45
 Quartile 1 (Referent) -- -- -- --
 Quartile 2 0.60[0.29,1.25] 0.61[0.29,1.32] 0.64[0.30,1.39] 0.65[0.30,1.42]
 Quartile 3 0.81 [0.41,1.58] 0.82 [0.40,1.68] 0.78[0.38,1.64] 0.84[0.40,1.77]
 Quartile 4 1.11[0.60,2.07] 1.12[0.58,2.18] 1.07[0.55,2.12] 1.18[0.59,2.33]
SAA continuous (per SD=22.6) 1.1 (0.93 1.2) 0.39 1.1 (0.94, 1.2) 0.34 1.1 (0.93, 1.2) 0.34 1.1 (0.95, 1.2) 0.25
SAA 0.56 0.50 0.43 0.39
 Quartile 1 (Referent) -- -- -- --
 Quartile 2 0.71[0.39,1.29] 0.71[0.39,1.31] 0.68[0.37,1.26] 0.67[0.36,1.25]
 Quartile 3 0.75 [0.42,1.36] 0.76[0.42,1.38] 0.74[0.40,1.36] 0.72[0.39,1.34]
 Quartile 4 0.98[0.57,1.70] 1.05[0.60,1.84] 1.04[0.59,1.85] 1.04[0.59,1.85]
TNFR1 continuous (per SD=1.46) 1.2 (1.0, 1.4) 0.049 1.2 (0.99, 1.4) 0.054 1.1 (0.94, 1.3) 0.21 1.1 (0.95, 1.4) 0.15
TNFR1 0.17 0.19 0.37 0.30
 Quartile 1 (Referent) -- -- -- --
 Quartile 2 0.92[0.46,1.81] 0.90[0.45,1.78] 0.83[0.41,1.66] 0.83[0.41,1.67]
 Quartile 3 1.51 [0.82,2.76] 1.45[0.79,2.67] 1.37[0.74,2.54] 1.43[0.77,2.66]
 Quartile 4 1.61[0.88,2.95] 1.62[0.87,3.00] 1.33[0.71,2.50] 1.36[0.72,2.56]
CD40L continuous (per SD=4.39) 0.99 (0.80, 1.2) 0.89 1.0 (0.83,1.3) 0.73 0.99 (0.78, 1.3) 0.92 0.98 (0.77, 1.2) 0.86
CD40L 0.80 0.93 0.82 0.81
 Quartile 1 (Referent) -- -- -- --
 Quartile 2 1.03[0.58,1.80] 1.00[0.57,1.76] 1.10[0.62,1.94] 1.09[0.61,1.93]
 Quartile 3 0.81 [0.45,1.47] 0.84[0.46,1.54] 0.87[0.48,1.60] 0.91[0.49,1.67]
 Quartile 4 0.82[0.45,1.50] 0.91[0.49,1.70] 0.83[0.43,1.59] 0.80[0.42,1.53]
  1. Unadjusted
  2. Adjusted for Demographics (Age, Sex, Race, Region)
  3. Adjusted for Demographics (Age, Sex, Race, Region) and Co-morbidities (Hypertension, Smoking, History of Prior Ischemic Stroke, Diabetes, LDL and HDL)
  4. Adjusted for Demographics (Age, Sex, Race, Region) Co-morbidities (Hypertension, Smoking, History of Prior Ischemic Stroke, Diabetes, Low Density Lipoprotein and High Density Lipoprotein) and Statin use at baseline